XKRX:330350 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
6,560
-120 (-1.8%)
Apr 25
What is a stock summary page? Click here for an overview.
Business Description
Withus Pharmaceutical Co Ltd
ISIN : KR7330350000
Share Class Description:
XKRX:330350: Ordinary SharesCompare
Compare
Traded in other countries / regions
330350.Korea Index Membership
KOSDAQ Composite Index IPO Date
2020-07-03Description
Withus Pharmaceutical Co Ltd is a pharmaceutical company. The firm is engaged in the manufacturing and selling of various medicines such as Broazette long-acting tablet, Wipina tablets, Mantini tablets, and Choline syrup among others.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.79 | |||||
| Equity-to-Asset | 0.69 | |||||
| Debt-to-Equity | 0.26 | |||||
| Debt-to-EBITDA | 2.5 | |||||
| Interest Coverage | 6.95 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 3.19 | |||||
| Beneish M-Score | -2.79 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 21.3 | |||||
| 3-Year EBITDA Growth Rate | 11.2 | |||||
| 3-Year EPS without NRI Growth Rate | 11.2 | |||||
| 3-Year Book Growth Rate | 4.8 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.69 | |||||
| 9-Day RSI | 58.51 | |||||
| 14-Day RSI | 57.8 | |||||
| 3-1 Month Momentum % | -12.05 | |||||
| 6-1 Month Momentum % | -13.68 | |||||
| 12-1 Month Momentum % | -24.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | |||||
| Quick Ratio | 1.33 | |||||
| Cash Ratio | 0.56 | |||||
| Days Inventory | 161.43 | |||||
| Days Sales Outstanding | 89.46 | |||||
| Days Payable | 46.22 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -2.04 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 63.82 | |||||
| Operating Margin % | 5.51 | |||||
| Net Margin % | 4.66 | |||||
| FCF Margin % | 2.99 | |||||
| ROE % | 5.23 | |||||
| ROA % | 3.63 | |||||
| ROIC % | 4.89 | |||||
| 3-Year ROIIC % | 3.46 | |||||
| ROC (Joel Greenblatt) % | 7.64 | |||||
| ROCE % | 5.87 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 18.18 | |||||
| PE Ratio without NRI | 16.14 | |||||
| PS Ratio | 0.83 | |||||
| PB Ratio | 0.92 | |||||
| Price-to-Tangible-Book | 1.05 | |||||
| Price-to-Free-Cash-Flow | 29.07 | |||||
| Price-to-Operating-Cash-Flow | 9.06 | |||||
| EV-to-EBIT | 15.66 | |||||
| EV-to-EBITDA | 9.52 | |||||
| EV-to-Revenue | 0.88 | |||||
| EV-to-FCF | 30.09 | |||||
| Price-to-GF-Value | 0.5 | |||||
| Price-to-Graham-Number | 0.87 | |||||
| Price-to-Net-Current-Asset-Value | 4.42 | |||||
| Earnings Yield (Greenblatt) % | 6.39 | |||||
| FCF Yield % | 3.54 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Withus Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 102,721.787 | ||
| EPS (TTM) (â‚©) | 361 | ||
| Beta | 0.89 | ||
| 3-Year Sharpe Ratio | -0.34 | ||
| 3-Year Sortino Ratio | -0.51 | ||
| Volatility % | 17.88 | ||
| 14-Day RSI | 57.8 | ||
| 14-Day ATR (â‚©) | 231.448504 | ||
| 20-Day SMA (â‚©) | 6316 | ||
| 12-1 Month Momentum % | -24.44 | ||
| 52-Week Range (â‚©) | 5610 - 9280 | ||
| Shares Outstanding (Mil) | 13.2 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Withus Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Withus Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Withus Pharmaceutical Co Ltd Frequently Asked Questions
What is Withus Pharmaceutical Co Ltd(XKRX:330350)'s stock price today?
The current price of XKRX:330350 is â‚©6560.00. The 52 week high of XKRX:330350 is â‚©9280.00 and 52 week low is â‚©5610.00.
When is next earnings date of Withus Pharmaceutical Co Ltd(XKRX:330350)?
The next earnings date of Withus Pharmaceutical Co Ltd(XKRX:330350) is .
Does Withus Pharmaceutical Co Ltd(XKRX:330350) pay dividends? If so, how much?
Withus Pharmaceutical Co Ltd(XKRX:330350) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers